PFIZER INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 520 25
 
 
C07D HETEROCYCLIC COMPOUNDS 382 15
 
 
C07K PEPTIDES 103 48
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 47 121
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 40 14
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 38 100
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 26 67
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 23 77
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 21 80
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12 186
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0011,103 CIRCULATING TUMOR CELL ASSAY Jul 27, 17 Jan 11, 18 [G01N]
2018/0000,885 Therapeutic Nanoparticles With High Molecular Weight Copolymers Jun 15, 17 Jan 04, 18 [A61K]
2018/0000,922 Immunogenic Compositions for Use in Pneumococcal Vaccines Jan 05, 16 Jan 04, 18 [A61K]
2018/0000,933 STABLE AQUEOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ANTIBODY FORMULATION Jan 20, 16 Jan 04, 18 [A61K, C07K]
2018/0002,330 Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof Jan 29, 16 Jan 04, 18 [C07D]
2018/0002,331 5,7-Dihydro-Pyrrolo-Pyridine Derivatives Jun 29, 17 Jan 04, 18 [C07D]
2018/0002,428 ANTI-CXCR4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES May 31, 17 Jan 04, 18 [A61K, C07K]
2017/0368,070 COMBINATION THERAPY FOR TUBERCULOSIS Jul 10, 17 Dec 28, 17 [A61K]
2017/0369,506 N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES Aug 16, 17 Dec 28, 17 [C07D]
2017/0360,929 STABLE AQUEOUS ANTIBODY FORMULATION FOR ANTI TNF ALPHA ANTIBODIES Dec 09, 15 Dec 21, 17 [A61K, C07K]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9877923 Process for preparing therapeutic nanoparticles Sep 16, 13 Jan 30, 18 [A61K]
9879022 Bicyclic-fused heteroaryl or aryl compounds Aug 10, 16 Jan 30, 18 [C07F, C07D, C07C, A61K]
9872848 Stable formulations for lyophilizing therapeutic particles Oct 18, 16 Jan 23, 18 [C08G, A61K]
9872913 Drug loaded polymeric nanoparticles and methods of making and using same May 23, 16 Jan 23, 18 [C07C, A61K, A61J, B82Y]
9872922 Anti-EFNA4 antibody-drug conjugates Jun 08, 16 Jan 23, 18 [A61K, C07K]
9873673 2-thiopyrimidinones Jun 24, 16 Jan 23, 18 [C07D, A61K]
9873690 3-indol substituted derivatives, pharmaceutical compositions and methods for use Mar 17, 16 Jan 23, 18 [C07D, A61K]
9868744 Heteroaromatic compounds and their use as dopamine D1 ligands Apr 13, 15 Jan 16, 18 [C07D]
9861638 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one Apr 28, 15 Jan 09, 18 [C07D, C07C, A61K]
9856263 Heteroaromatic compounds and their use as dopamine D1 ligands Apr 15, 15 Jan 02, 18 [C07D]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0233,371 RORC2 INHIBITORS AND METHODS OF USE THEREOF ABAN Apr 26, 17 Aug 17, 17 [C07D]
2017/0197,939 Tropomyosin-Related Kinase Inhibitors Containing Both A 1H-Pyrazole And A Pyrimidine Moiety ABAN Apr 01, 15 Jul 13, 17 [C07D, A61K]
2017/0050,958 Cycloalkyl-Linked Diheterocycle Derivatives ABAN Apr 17, 15 Feb 23, 17 [C07D, A61K]
2016/0376,254 SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS ABAN Sep 12, 16 Dec 29, 16 [C07D, C07B]
2016/0362,392 GLUCAGON RECEPTOR MODULATORS ABAN Aug 26, 16 Dec 15, 16 [C07D]
2016/0311,805 ANTI-ESTROGENIC COMPOUNDS ABAN Apr 22, 16 Oct 27, 16 [C07D]
2016/0272,625 HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF ABAN Jun 01, 16 Sep 22, 16 [C07D, C07C]
2016/0243,101 APIXABAN FORMULATIONS ABAN Mar 31, 16 Aug 25, 16 [A61K]
2016/0221,989 N-Acylpyrrolidine Ether Tropomyosin-Related Kinase Inhibitors ABAN Aug 04, 15 Aug 04, 16 [C07D, A61K]
2016/0220,557 USE OF ACETYL-COA CARBOXYLASE INHIBITORS FOR TREATING ACNE VULGARIS ABAN Aug 29, 14 Aug 04, 16 [A61K]
2016/0220,578 Combination Therapy for Tuberculosis ABAN Oct 06, 15 Aug 04, 16 [A61K]
2016/0207,991 Therapeutic Antibody ABAN Sep 01, 15 Jul 21, 16 [A61K, C07K]
2016/0206,608 CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER ABAN Jul 24, 12 Jul 21, 16 [A61K]
2016/0151,298 DOCETAXEL POLYMERIC NANOPARTICLES AND METHODS OF TREATING CANCERS USING SAME ABAN Jun 27, 14 Jun 02, 16 [A61K]
2016/0136,170 USE OF A TETRASUBSTITUTED PYRAZOLO[4, 3-D]PYRIMIDINE COMPOUND FOR TREATING DIABETIC NEPHROPATHY ABAN Jan 21, 16 May 19, 16 [A61K]
2016/0102,074 SUBSTITUTED AMIDE COMPOUNDS ABAN Sep 29, 15 Apr 14, 16 [C07D, A61K]
2016/0096,898 PC33718E ABAN Sep 24, 15 Apr 07, 16 [C07K]
2016/0045,608 LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS ABAN Oct 26, 15 Feb 18, 16 [A61K]
2016/0016,907 PYRIDINE DERIVATIVES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS ABAN Jul 15, 15 Jan 21, 16 [C07D]
2015/0376,185 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS ABAN Sep 11, 15 Dec 31, 15 [C07D, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

Owner Watch
PFIZER INC.
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL